The company manufactures refractory ceramic products primarily for the steel industry and operates a small solar power generation unit.
The company operates in a highly cyclical, commodity-like industry with no evidence of pricing power, as reflected by low and volatile net margins (avg 2.6%) and ROCE (8.7%) that barely covers the cost of capital.
Management prioritizes internal liquidity and debt reduction over shareholder returns, with no dividends paid despite consistent profits. Significant capital was recently used to redeem preference shares at a substantial premium, which may not be the most efficient use of owner capital.
Five years out, the capital loss was driven by a combination of governance decay and capital misallocation. The management's habit of prioritizing related-party interests over minority shareholders culminated in the redemption of preference shares at massive premiums, draining the company's cash reserves. As the commodity cycle turned, the business lacked the pricing power to defend its already thin margins, and the persistent regulatory non-compliance finally triggered exchange-level sanctions or delisting, leaving investors holding illiquid shares in a stagnant, poorly governed entity that failed to earn its cost of capital.
RichFakir rates Associated Ceramics Ltd's business quality as poor — 27/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Associated Ceramics Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Associated Ceramics Ltd is: Not rated. A poor business at an expensive price — it does not make our shortlist right now. We marked it down a notch: revenue and earnings barely grow — a steady cash cow, not a compounder.
RichFakir's educational estimate of Associated Ceramics Ltd's fair value is about ₹79 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →